Mobiamedical
3 known investors
Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.
Founders & leadership
JC
Jordan CurnesinCo-Founder
Investors Β· 3
Frequently asked questions
- What does Mobiamedical do?
- Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.
- Who founded Mobiamedical?
- Mobiamedical was founded by Jordan Curnes.
- Who are Mobiamedical's investors?
- Mobiamedical's investors include Green Park & Golf Ventures, OUP (Osage University Partners), US Venture Partners.